Advertisement
Screener

PERNIX THERAPEUTICS HOLDINGS, INC. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities

PERNIX THERAPEUTICS HOLDINGS, INC. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities

PERNIX THERAPEUTICS HOLDINGS, INC. reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of $2.44 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-13.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2018-11-13

  • PERNIX THERAPEUTICS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2018-09-30 was $4.73M, a 88.07% increase year-over-year.
  • PERNIX THERAPEUTICS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2018-06-30 was -$6.24M.
  • PERNIX THERAPEUTICS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2018-03-31 was $3.95M.
  • PERNIX THERAPEUTICS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2017-12-31 was -$1.95M, a 142.23% decline year-over-year.
  • PERNIX THERAPEUTICS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2017 was -$4.65M.
  • PERNIX THERAPEUTICS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2016 was -$1.72M, a 117.04% decline from fiscal 2015.
  • PERNIX THERAPEUTICS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2015 was $10.07M, a 45.00% decline from fiscal 2014.
  • PERNIX THERAPEUTICS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2014 was $18.32M.
Period endIncrease (Decrease) in Other Accounts Payable and Accrued Liabilities 3 monthIncrease (Decrease) in Other Accounts Payable and Accrued Liabilities 6 monthIncrease (Decrease) in Other Accounts Payable and Accrued Liabilities 9 monthIncrease (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month
2018-09-30$4.73M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
-$1.50M
derived: sum of 2 quarters · filed 2018-11-13
$2.44M
10-Q · filed 2018-11-13
$496.00K
derived: sum of 4 quarters · filed 2018-11-13
2018-06-30-$6.24M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
-$2.29M
10-Q · filed 2018-08-09
-$4.23M
derived: sum of 3 quarters · filed 2018-08-09
-$1.72M
derived: sum of 4 quarters · filed 2018-11-13
2018-03-31$3.95M
10-Q · filed 2018-05-10
$2.00M
derived: sum of 2 quarters · filed 2018-05-10
$4.52M
derived: sum of 3 quarters · filed 2018-11-13
$4.45M
derived: sum of 4 quarters · filed 2018-11-13
2017-12-31-$1.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08
$570.00K
derived: sum of 2 quarters · filed 2018-11-13
$499.00K
derived: sum of 3 quarters · filed 2018-11-13
-$4.65M
10-K · filed 2018-03-08
2017-09-30$2.52M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
$2.44M
derived: sum of 2 quarters · filed 2018-11-13
-$2.71M
10-Q · filed 2018-11-13
$1.90M
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30-$71.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
-$5.22M
10-Q · filed 2018-08-09
-$616.00K
derived: sum of 3 quarters · filed 2018-08-09
-$7.00K
derived: sum of 4 quarters · filed 2018-08-09
2017-03-31-$5.15M
10-Q · filed 2018-05-10
-$545.00K
derived: sum of 2 quarters · filed 2018-05-10
$64.00K
derived: sum of 3 quarters · filed 2018-05-10
-$6.67M
derived: sum of 4 quarters · filed 2018-05-10
2016-12-31$4.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08
$5.21M
derived: sum of 2 quarters · filed 2018-03-08
-$1.52M
derived: sum of 3 quarters · filed 2018-03-08
-$1.72M
10-K · filed 2018-03-08
2016-09-30$609.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
-$6.13M
derived: sum of 2 quarters · filed 2017-11-07
-$6.32M
10-Q · filed 2017-11-07
-$1.60M
derived: sum of 4 quarters · filed 2017-11-07
2016-06-30-$6.74M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27
-$6.93M
10-Q · filed 2017-07-27
-$2.21M
derived: sum of 3 quarters · filed 2017-07-27
$3.55M
derived: sum of 4 quarters · filed 2017-07-27
2016-03-31-$195.00K
10-Q · filed 2017-05-15
$4.53M
derived: sum of 2 quarters · filed 2017-05-15
$10.29M
derived: sum of 3 quarters · filed 2017-05-15
$10.75M
derived: sum of 4 quarters · filed 2017-05-15
2015-12-31$4.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-28
$10.48M
derived: sum of 2 quarters · filed 2017-03-28
$10.94M
derived: sum of 3 quarters · filed 2017-03-28
$10.07M
10-K · filed 2017-03-28
2015-09-30$5.76M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
$6.22M
derived: sum of 2 quarters · filed 2016-11-10
$5.35M
10-Q · filed 2016-11-10
$23.67M
derived: sum of 4 quarters · filed 2016-11-10
2015-06-30$461.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11
-$406.00K
10-Q · filed 2016-08-11
$17.91M
derived: sum of 3 quarters · filed 2016-08-11
$17.91M
derived: sum of 4 quarters · filed 2016-08-11
2015-03-31-$867.00K
10-Q · filed 2016-05-05
$17.45M
derived: sum of 2 quarters · filed 2016-05-05
$17.45M
derived: sum of 3 quarters · filed 2016-05-05
$12.73M
derived: sum of 4 quarters · filed 2016-05-05
2014-12-31$18.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10
$18.32M
derived: sum of 2 quarters · filed 2016-03-10
$13.60M
derived: sum of 3 quarters · filed 2016-03-10
$18.32M
10-K · filed 2016-03-10
2014-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
-$4.72M
derived: sum of 2 quarters · filed 2015-11-05
$0.00
10-Q · filed 2015-11-05
2014-06-30-$4.72M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$0.00
10-Q · filed 2015-08-06
2014-03-31$4.72M
10-Q · filed 2015-05-01
2013-12-31-$3.08M
10-K · filed 2016-03-10